Kessler Judd S 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-01 12:57 pm Purchase | 2024-05-01 | 13D | Calidi Biotherapeutics, Inc. CLDI | Kessler Judd S | 31,082 5.000% | 31,082 (New Position) | Filing |